Alzamend Neuro's AL001 study highlights safety and therapeutic potential for Alzheimer's and psychiatric conditions, reducing systemic side effects.
Researchers have demonstrated that cannabinol (CBN), a compound found in aged cannabis, improves sleep in rats.